Speaker illustration

Professor Yu Wang

1st Affiliated Hospital of Kunming Medical University, Kunming (China)

Member of:

European Society of Cardiology

Chief Physician, M.D., Master Supervisor, Leading Figure in the Medical Discipline of Yunnan Province, Visiting Scholar at the Mayo Clinic in the United States. Specializes in ultrasound diagnosis and treatment of fetal, pediatric, and adult cardiovascular diseases, as well as extracorporeal shock wave therapy for coronary heart disease. In medical education and research, excels in the following areas: Starting from patient needs, proficient in applying new echocardiography technologies to clinical practice, such as rapid identification of cardiovascular emergencies and coronary microcirculation disorders using contrast echocardiography, transesophageal three-dimensional ultrasound-guided structural heart disease interventions, extracorporeal shock wave therapy for ischemic heart disease, tissue synchronization imaging for assessing and evaluating cardiac resynchronization therapy (CRT-D) effects, and speckle tracking imaging for early detection of cardiac dysfunction in KD.

CSWT improves ventricular function by promoting angiogenesis through Rho/ROCK/ERK1/2 signal pathway in infarcted myocardium in rats

Event: ESC Congress 2024

Topic: Revascularisation

Session: Pharmacotherapy in coronary artery disease: from bench to bedside (2)

Thumbnail

The relationship between coronary microvascular dysfunction and left ventricular longitudinal systolic function in patients with diabetes mellitus

Event: ESC Congress 2024

Topic: Coronary Microcirculation and Collaterals

Session: Detection of microvascular dysfunction (2)

Thumbnail

Early CSWT relieves myocardial fibrosis by inhibiting TGF-Smad2/3-MMP-9

Event: ESC Congress 2024

Topic: Nonpharmacological Treatment

Session: Experimental studies in coronary atherosclerosis disease

Thumbnail